Activated Carbon For Pharma & Healthcare Market To Reach $652.1 Million By 2030

May 2025 | Report Format: Electronic (PDF)

Activated Carbon For Pharma & Healthcare Market Growth & Trends

The global activated carbon for pharma & healthcare market size is anticipated to reach USD 652.1 million by 2030 and is expected to grow at a CAGR of 6.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. The demand for activated carbon in the pharmaceutical and healthcare sectors continues to grow, largely due to its exceptional ability to purify and adsorb contaminants. In hospitals, it plays a vital role in maintaining clean air and water, while in pharmaceutical manufacturing, it's used to remove impurities and unwanted colorants from medications. Medical-grade activated carbon, approved for human use, is also a critical tool in emergency medicine for treating poisonings. It works by binding to toxins in the gastrointestinal tract, stopping them from being absorbed into the body, a life-saving measure in cases of overdose or accidental ingestion.

This rising demand is also tied to the significant challenge posed by hospital-acquired infections (HAIs) in the U.S. Each year, approximately 1.7 million patients, roughly 5% to 10% of those hospitalized, develop an HAI, with close to 100,000 resulting deaths. These numbers highlight a serious public health concern that exceeds the impact of many other major diseases. To combat this, healthcare facilities are turning to advanced purification technologies, with activated carbon being a top choice due to its efficiency in filtering harmful particles and pathogens.

In addition, activated carbon is heavily utilized in the pharmaceutical industry for its high porosity and excellent adsorption capabilities, which are enhanced through thermal processing. These properties allow it to effectively remove contaminants, pigments, and residues during drug production, improving the final product's quality and safety.


key Request a free sample copy or view report summary: Activated Carbon For Pharma & Healthcare Market Report


Activated Carbon For Pharma & Healthcare Market Highlights

  • Based on form, the powdered form dominated the market with the largest revenue share of 56.3% in 2024.

  • The granular activated carbon market for the pharmaceutical and healthcare industry is estimated to grow at the fastest CAGR over the forecast period.

  • Its superior absorption, easy handling, storage, and ability to withstand repeated filtration cycles drive the growth.

  • Based on application, API production led the activated carbon market for the pharma & healthcare industry, accounting for the largest revenue share in 2024.

  • The finished drug production segment is expected to grow at a significant CAGR of 6.2% over the forecast period.

  • Asia Pacific dominated the global market with the largest revenue share of 48.6% in 2024.

  • The rise in pharmaceutical production across Asian countries fueled the demand for more efficient purification methods during production.

Activated Carbon For Pharma & Healthcare Market Segmentation

Grand View Research has segmented the global activated carbon for pharma & healthcare market based on form, application, and region:

Activated Carbon For Pharma & Healthcare Form Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

  • Powdered

  • Granular

  • Other Form

Activated Carbon For Pharma & Healthcare Application Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

  • API Production

  • Finished Drug Production

  • Others

Activated Carbon For Pharma & Healthcare Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

  • Asia Pacific

    • China

    • India

    • Japan

    • South Korea

    • Australia

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

List of Key Players in the Activated Carbon For Pharma & Healthcare Market

  • Jacobi Group

  • Chemviron (a Kuraray Company)

  • Haycarb PLC

  • Boyce Carbon

  • Southern Carbon Pvt. Ltd.

  • Suneeta Carbons

  • Calgon Carbon Corporation

  • Karbonous Inc.

  • Norit

  • Donau Carbon GmbH

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We offer custom report options, including stand-alone sections and country-level data. Special pricing is available for start-ups and universities.

Request Customization